Landmark analysis at D28: long-term outcomes according to day 28 response to second line therapy. (A) Cumulative incidence of NRM and (B) Kaplan-Meier estimates of OS for patients according to D28 response (CR, PR, or NR). The gray test was used for the group comparison of NRM and the log-rank test was used for the group comparison of OS. NR, no response.